Abeona Therapeutics Inc. (ABEO) stock
ABEONasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 9, 2026Score 8/3039% below fair value
$2.42+0.13 (+5.68%)
Close on Nov 13, 2026Market cap $138.39MP/E –Yield –
Abeona Therapeutics statistics
86 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.
Important dates
- Next earnings
- Mar 16, 2027 (estimated, before the open)
- Last ex-dividend date
- Mar 31, 2000
- Fundamentals through
- Sep 30, 2026
- Share price as of
- Nov 13, 2026
Valuation ratiosIndustry
- P/TBV Ratio
- 1.10
- 2.22
Enterprise valuationIndustry
- EV / Sales
- 0.39
- 2.57
Share statisticsIndustry
- Shares Change (YoY)
- 8.84%
- 10.8%
- Shares Change (QoQ)
- -0.10%
- 0.50%
- Float
- 50M
- 49M
- Shares Held by Insiders
- 12.3%
- 11.7%
- Shares Held by Institutions
- 77.9%
- 56.4%
Short sellingIndustry
- Short Interest
- 17M
- –
- Short Interest Change
- -1.95%
- -0.80%
- Short % of Float
- 33.6%
- 9.01%
- Short % of Shares Outstanding
- 29.5%
- 6.30%
- Days to Cover
- 21.67
- 5.15
Stock price statisticsIndustry
- 52-Week High
- $7.65
- –
- 52-Week Low
- $2.09
- –
- 20-Day Moving Average
- $3.87
- –
- 50-Day Moving Average
- $4.70
- –
- 200-Day Moving Average
- $5.40
- –
- Average True Range (14)
- $0.33
- –
- Price Change (1 Week)
- -42.0%
- -1.15%
- Price Change (1 Month)
- -48.0%
- -4.87%
- Price Change (3 Months)
- -59.3%
- -21.0%
- Price Change (6 Months)
- -55.9%
- -20.6%
- Price Change (YTD)
- -54.1%
- -23.6%
- Price Change (1 Year)
- -51.0%
- -22.4%
- Price Change (3 Years)
- -43.1%
- -29.5%
- Price Change (5 Years)
- -89.5%
- -77.9%
- Price Change (10 Years)
- -98.7%
- -65.4%
- Average Volume (10 Days)
- 3M
- –
- Average Volume (20 Days)
- 2M
- –
- Average Volume (90 Days)
- 2M
- –
- Relative Volume
- 2.05
- 0.70
- Relative Strength Index (14)
- 21.4
- 43.4
- Volatility (1 Year)
- 64.6%
- 80.1%
- Beta (5 Years)
- 1.30
- 1.07
MarginsIndustry
- Pretax Margin
- -160.8%
- -11.6%
- EBITDA Margin
- -178.5%
- -27.7%
- FCF Margin
- -170.1%
- -9.56%
Returns on capitalIndustry
- Return on Equity (ROE)
- -42.1%
- -49.9%
- Return on Assets (ROA)
- -31.0%
- -40.6%
- Return on Capital Employed (ROCE)
- -50.3%
- -37.9%
Financial positionIndustry
- Current Ratio
- 5.69
- 3.30
- Quick Ratio
- 5.44
- 2.39
- Debt / Equity
- 0.09
- 0.49
- Interest Coverage
- -24.47
- -6.35
GrowthIndustry
- Net Income Growth (YoY)
- -175.9%
- -14.4%
- Revenue Growth (3Y CAGR)
- 60.3%
- 2.25%
- Revenue Growth (5Y CAGR)
- -10.3%
- 6.41%
EfficiencyIndustry
- Asset Turnover
- 0.19
- 0.40
- Inventory Turnover
- 2.87
- 2.73
- Revenue Per Employee
- $172.62K
- $429.29K
- Profits Per Employee
- -$276.70K
- -$689.41K
- Employee Count
- 226
- 74
- WACC
- 11.6%
- 10.2%
Income statement (TTM)Industry
- Pretax Income
- -$62.73M
- -$12.95M
Balance sheetIndustry
- Net Cash (Debt)
- $123.10M
- $17.76M
- Net Cash Per Share
- $2.15
- $0.80
- Equity (Book Value)
- $125.88M
- $53.89M
- Book Value Per Share
- $2.20
- $1.50
- Tangible Book Value
- $125.88M
- $27.13M
- Working Capital
- $130.01M
- $79.99M
Cash flow (TTM)Industry
- Capital Expenditures
- -$2.79M
- -$1.00M
- FCF Per Share
- -$1.16
- -$0.42
Dividends and yieldsIndustry
- Earnings Yield
- -45.2%
- -21.8%
- FCF Yield
- -47.9%
- -9.44%
Taxes and interestIndustry
- Interest Expense
- $2.97M
- $2.90M
- Income Tax
- -$195.00K
- $73.00K
Scores and fair valueIndustry
- Altman Z-Score
- -4.84
- 0.23
- Piotroski F-Score
- 4
- 4
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 13, 2026. The S&P 500 is measured by the SPY fund.
| Period | ABEO | S&P 500 | Difference | ABEO per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | -46.5% | -3.0% | −43.4 pts | ||
| 3 months | -61.9% | -2.8% | −59.1 pts | ||
| Year to date | -54.1% | +11.5% | −65.6 pts | ||
| 1 year | -46.6% | +13.5% | −60.0 pts | ||
| 3 years | -46.2% | +77.7% | −123.9 pts | -18.7% | +21.1% |
| 5 years | -89.5% | +72.6% | −162.1 pts | -36.3% | +11.5% |
| 10 years | -98.5% | +308.2% | −406.7 pts | -34.3% | +15.1% |
Short interest
Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.
17M ABEO shares were sold short on Oct 30, 2026, down 1.9% from the previous report, or 33.65% of the shares available to trade. At recent volumes it would take 21.7 days to buy them back. Over the last 20 sessions, 45.5% of the volume reported to FINRA was short selling.
| Settlement date | Shares short | Change | Avg. daily volume | Days to cover |
|---|---|---|---|---|
| Oct 30, 2026 | 16,879,896 | -1.9% | 778,947 | 21.7 |
| Oct 15, 2026 | 17,214,886 | +2.0% | 1,355,757 | 12.7 |
| Sep 30, 2026 | 16,882,889 | +7.2% | 1,459,538 | 11.6 |
| Sep 15, 2026 | 15,745,098 | +3.9% | 1,312,757 | 12.0 |
| Aug 31, 2026 | 15,157,188 | +6.2% | 1,088,229 | 13.9 |
| Aug 14, 2026 | 14,271,165 | +4.6% | 2,077,722 | 6.9 |
| Jul 31, 2026 | 13,639,416 | +3.1% | 1,057,960 | 12.9 |
| Jul 15, 2026 | 13,233,189 | -3.3% | 1,598,144 | 8.3 |
| Jun 30, 2026 | 13,680,180 | -3.2% | 1,577,112 | 8.7 |
| Jun 15, 2026 | 14,137,986 | -1.8% | 860,472 | 16.4 |
| May 29, 2026 | 14,393,465 | -0.5% | 877,332 | 16.4 |
| May 15, 2026 | 14,467,961 | -12.2% | 1,415,092 | 10.2 |
Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.
See a number that looks wrong?